# AZD1981 Bioavailability Study of Intravenous (IV) and Oral Formulations

> **NCT00918398** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 14 (estimated)

## Conditions studied

- Healthy
- Postmenopausal
- Surgically Sterile Women

## Interventions

- **DRUG:** AZD1981
- **DRUG:** AZD1981
- **DRUG:** AZD1981
- **DRUG:** AZD1981

## Key facts

- **NCT ID:** NCT00918398
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** —
- **Final completion:** 2009-07
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2009-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00918398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00918398, "AZD1981 Bioavailability Study of Intravenous (IV) and Oral Formulations". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00918398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*